US 11905332
Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11905332 (Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 43
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K39/3955